Medical Microbiology and Immunology

期刊简介：Medical Microbiology and Immunology (MMIM) publishes key findings on all aspects of the interrelationship between infectious agents and the immune system of their hosts. The journal´s main focus is original research work on intrinsic, innate or adaptive immune responses to viral, bacterial, fungal and parasitic (protozoan and helminthic) infections and on the virulence of the respective infectious pathogens.MMIM covers basic, translational as well as clinical research in infectious diseases and infectious disease immunology. Basic research using cell cultures, organoid, and animal models are welcome, provided that the models have a clinical correlate and address a relevant medical question.The journal also considers manuscripts on the epidemiology of infectious diseases, including the emergence and epidemic spreading of pathogens and the development of resistance to anti-infective therapies, and on novel vaccines and other innovative measurements of prevention.The following categories of manuscripts will not be considered for publication in MMIM:submissions of preliminary work, of merely descriptive data sets without investigation of mechanisms or of limited global interest,manuscripts on existing or novel anti-infective compounds, which focus on pharmaceutical or pharmacological aspects of the drugs,manuscripts on existing or modified vaccines, unless they report on experimental or clinical efficacy studies or provide new immunological information on their mode of action,manuscripts on the diagnostics of infectious diseases, unless they offer a novel concept to solve a pending diagnostic problem,case reports or case series, unless they are embedded in a study that focuses on the anti-infectious immune response and/or on the virulence of a pathogen.

【译文】医学微生物学和免疫学（MMIM）发表关于感染性病原体与其宿主免疫系统之间相互关系的所有方面的关键发现。该期刊的主要重点是关于病毒、细菌、真菌和寄生虫（原生动物和蠕虫）感染的内源、先天或适应性免疫反应的原创新研究工作，以及相应感染病原体的致病性。MMIM涵盖传染病和传染病免疫学的基础、转化以及临床研究。欢迎使用细胞培养、类器官和动物模型进行基础研究，前提是这些模型具有临床相关性并解决相关的医学问题。该期刊还考虑关于传染病流行病学的研究论文，包括病原体的出现和流行传播以及对抗感染疗法的耐药性发展，以及新型疫苗和其他创新预防措施。以下类型的论文将不会考虑在MMIM上发表：初步工作提交、仅描述性数据集且未调查机制或全球兴趣有限的论文、仅关注药物药理方面的现有或新型抗感染化合物论文、除非它们报告了实验或临床疗效研究或提供了关于其作用机制的新免疫学信息，除非它们提供了解决待诊问题的创新概念，否则不会考虑关于传染病诊断的论文、除非它们嵌入在专注于抗感染免疫反应和/或病原体致病性的研究中，除非它们是嵌入在专注于抗感染免疫反应和/或病原体致病性的研究中，病例报告或病例系列。